MedPath

Study of the early prediction and evaluation of the effect of Jianpi Bushen Decoction on Avascular Necrosis of the Femoral Head at ARCO stages 2 and 3 based on CT radiomics and deep learning

Phase 1
Recruiting
Conditions
Avascular Necrosis of the Femoral Head
Registration Number
ITMCTR2022000052
Lead Sponsor
Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Patients with avascular necrosis of the femoral head treated with Jianpi Bushen Decoction with the syndrome of phlegm and blood stasis blocking collaterals, and the age is greater than or equal to 18 years old. All patients signed informed consent and voluntarily participated in this trial.

Exclusion Criteria

?Age less than 18 years old;
?Rheumatic immune diseases, such as connective tissue disease, ankylosing spondylitis, etc.;
?Severe hip osteoarthritis on the image;
?History of hip trauma;
?History of hip surgery or invasive examination and treatment;
?Incomplete clinical data, no Harris score of hip joint;
?Treatment time is less than 6 months;
?There is nofollow-up image data, or the image data is incomplete and the image quality is poor.

Study & Design

Study Type
Prognosis study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
femoral head collapse depth;CT Radiomics Features-Gray Statistical Features;CT radiomic features - shape features;CT radiomic features-texture features;
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath